Cargando…

A Novel Therapeutic Target in Inflammatory Uveitis: Transglutaminase 2 Inhibitor

PURPOSE: Our goal was to investigate the effects of inhibition of transglutaminase 2 (TGase 2) on endotoxin-induced uveitis (EIU) METHODS: EIU was induced in female Lewis rats by single footpad injections of 200 µg of lipopolysaccharide (LPS). TGase 2 inhibitors were administered intraperitoneally 3...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sohn, Joonhong, Chae, Ju Byung, Lee, Sun Young, Kim, Soo-Youl, Kim, June-Gone
Formato:	Texto
Lenguaje:	English
Publicado:	The Korean Ophthalmological Society 2010
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2817820/ https://www.ncbi.nlm.nih.gov/pubmed/20157411 http://dx.doi.org/10.3341/kjo.2010.24.1.29

Ejemplares similares

New Insights into Development of Transglutaminase 2 Inhibitors as Pharmaceutical Lead Compounds
por: Kim, Soo-Youl
Publicado: (2018)

A Precision Strategy to Cure Renal Cell Carcinoma by Targeting Transglutaminase 2
por: Kim, Soo-Youl, et al.
Publicado: (2020)

Ethacrynic Acid Inhibits Sphingosylphosphorylcholine-Induced Keratin 8 Phosphorylation and Reorganization via Transglutaminase-2 Inhibition
por: Byun, Hyun Jung, et al.
Publicado: (2013)

Suppression of Transglutaminase-2 is Involved in Anti-Inflammatory Actions of Glucosamine in 12-O-Tetradecanoylphorbol-13-Acetate-Induced Skin Inflammation
por: Park, Mi Kyung, et al.
Publicado: (2012)

Time-Lag between Subretinal Fluid and Pigment Epithelial Detachment Reduction after Polypoidal Choroidal Vasculopathy Treatment
por: Chae, Ju Byung, et al.
Publicado: (2011)

Inhibition of Transglutaminase 2 but Not of MDM2 Has a Significant Therapeutic Effect on Renal Cell Carcinoma
por: Kang, Joon Hee, et al.
Publicado: (2020)

Preliminary study of ultra-widefield peripheral retinal angiographic patterns in children and its association to the perinatal condition
por: Kim, Jin Young, et al.
Publicado: (2020)

The Therapeutic Effects of Bevacizumab in Patients with Polypoidal Choroidal Vasculopathy
por: Lee, Sun Young, et al.
Publicado: (2008)

Structural Recovery of the Detached Macula after Retinal Detachment Repair as Assessed by Optical Coherence Tomography
por: Joe, Soo Geun, et al.
Publicado: (2013)

Macular Gradient Measurement in Myopic Posterior Staphyloma Using Optical Coherence Tomography
por: Chae, Ju Byung, et al.
Publicado: (2011)

Transglutaminase 2: a novel therapeutic target for idiopathic pulmonary fibrosis using selective small molecule inhibitors
por: Fell, Shaun, et al.
Publicado: (2021)

Transglutaminase 2—a novel inhibitor of adipogenesis
por: Myneni, V D, et al.
Publicado: (2015)

Transglutaminase 2 as a Marker for Inflammation and Therapeutic Target in Sepsis
por: Su, Ting, et al.
Publicado: (2021)

Small Molecule Inhibitors Target the Tissue Transglutaminase and Fibronectin Interaction
por: Yakubov, Bakhtiyor, et al.
Publicado: (2014)

A Case of Ophthalmic Artery Occlusion Following Subcutaneous Injection of Epinephrine Mixed with Lidocaine into the Supratrochlear Area
por: Moon, Byung Gil, et al.
Publicado: (2017)

Discovery of a novel target for renal cell carcinoma: transglutaminase 2
por: Kang, J H, et al.
Publicado: (2016)

The Anti-Inflammatory Effects of Angiogenin in an Endotoxin Induced Uveitis in Rats
por: Park, Jihae, et al.
Publicado: (2020)

Renal Cell Carcinoma Is Abrogated by p53 Stabilization through Transglutaminase 2 Inhibition
por: Lee, Seon-Hyeong, et al.
Publicado: (2018)

Transglutaminase 2 Promotes Autophagy by LC3 Induction through p53 Depletion in Cancer Cell
por: Kang, Joon Hee, et al.
Publicado: (2019)

Transglutaminase 2 in cartilage homoeostasis: novel links with inflammatory osteoarthritis
por: Adamczyk, M.
Publicado: (2016)

Targeting transglutaminase 2 as a potential disease modifying therapeutic strategy for synucleinopathies
por: Zhang, Jie, et al.
Publicado: (2021)

Cystamine and cysteamine as inhibitors of transglutaminase activity in vivo
por: Jeitner, Thomas M., et al.
Publicado: (2018)

Cell-Impermeable Inhibitors Confirm That Intracellular Human Transglutaminase 2 Is Responsible for the Transglutaminase-Associated Cancer Phenotype
por: Gates, Eric W. J., et al.
Publicado: (2023)

Transglutaminase 2 mediates UV-induced skin inflammation by enhancing inflammatory cytokine production
por: Lee, Seok-Jin, et al.
Publicado: (2017)

Transglutaminase 2 Expression Predicts Progression Free Survival in Non-Small Cell Lung Cancer Patients Treated with Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor
por: Jeong, Jae-Heon, et al.
Publicado: (2013)

Transglutaminase 2 as an independent prognostic marker for survival of patients with non-adenocarcinoma subtype of non-small cell lung cancer
por: Choi, Chang-Min, et al.
Publicado: (2011)

Blood-retina barrier dysfunction in experimental autoimmune uveitis: the pathogenesis and therapeutic targets
por: Kim, Jeongtae, et al.
Publicado: (2022)

Transglutaminase 2 is associated with adverse colorectal cancer survival and represents a therapeutic target
por: Malkomes, Patrizia, et al.
Publicado: (2023)

Involvement of Transglutaminase-2 in α-MSH-Induced Melanogenesis in SK-MEL-2 Human Melanoma Cells
por: Kim, Hyun Ji, et al.
Publicado: (2014)

Risk of Acute Anterior Uveitis in Ankylosing Spondylitis According to the Type of Tumor Necrosis Factor-Alpha Inhibitor and History of Uveitis: A Nationwide Population-Based Study
por: Ahn, Soo Min, et al.
Publicado: (2022)

Comparison of Targeted Next-Generation and Sanger Sequencing for the BRCA1 and BRCA2 Mutation Screening
por: Park, Joonhong, et al.
Publicado: (2016)

Is monocyte- and macrophage-derived tissue transglutaminase involved in inflammatory processes?
por: Chrobok, Navina L., et al.
Publicado: (2016)

Therapeutic anti-inflammatory effects of luteolin on endotoxin-induced uveitis in Lewis rats
por: KANAI, Kazutaka, et al.
Publicado: (2016)

Local Myeloid-Derived Suppressor Cells Impair Progression of Experimental Autoimmune Uveitis by Alleviating Oxidative Stress and Inflammation
por: Lee, Jae-Young, et al.
Publicado: (2023)

Discovery of Potent and Specific Dihydroisoxazole Inhibitors of Human Transglutaminase 2
por: Klöck, Cornelius, et al.
Publicado: (2014)

Optical Coherence Tomography Angiography Findings of Macular Choriovitreal Membrane Secondary to Spontaneous Closure of Traumatic Macular Hole
por: Kim, You Na, et al.
Publicado: (2020)

Multicellular immune dynamics implicate PIM1 as a potential therapeutic target for uveitis
por: Li, He, et al.
Publicado: (2022)

Association between polycystic ovary syndrome and non-infectious uveitis
por: Lee, Chae Eun, et al.
Publicado: (2023)

Midazolam Ameliorates Hyperglycemia-Induced Glomerular Endothelial Dysfunction by Inhibiting Transglutaminase 2 in Diabetes
por: Seo, Jae-Ah, et al.
Publicado: (2022)

Biotechnological Applications of Transglutaminases
por: Rachel, Natalie M., et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_tha8ng8eb4t4o3apkrjtude9d2